PIPELINE
Overview
| Platform Technology | Name | Indication | Drug Candidate | in-vivo | Pre-Clinical | Phase 1 | Phase 2 | Phase 3 | Market | SIT/IIT | Sponsor |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Embeddable Microneedle |
SNM-LIP | Lipolysis | SIT | SNVIA | |||||||
| SNM-ALP | Hair Growth | SIT | SNVIA | ||||||||
| SNM-KEL | Keloid | SIT | SNVIA | ||||||||
| SNM-BCG | Tuberculosis Vaccine | Masan National Tuberculosis Hospital | |||||||||
| SNM-DIB | Diabetes | ||||||||||
| Therapeutic Polymer |
SNP-AD | Ophthalmology | SIT | 제약사 | |||||||
| SNP-AD | Surgery | SIT | 제약사 | ||||||||
| SNP-MCL | Dermatology | SIT | 제약사 |
| Platform Technology | Name | Indication | Candidate [Classification] |
In-Vivo | Non-Clinical | P.1 (exploratory) |
P.2 (exploratory) |
P.3 (confirmatory) |
Approval | Partnership |
|---|---|---|---|---|---|---|---|---|---|---|
| CDC Microneedle |
SNM-100 | Anti Obesity | Semaglutide | S Company | ||||||
| SNM-130 | Tuberculosis Vaccine Patch |
BCG | MNTH | |||||||
| SNM-131 | Smallpox Vaccine Patch |
Vaccinia | KDCA | |||||||
| SNM-162 | Anti Osteoporosis | Teriparatide | A Company | |||||||
| SNM-163 | Malaria Vaccine Patch |
Protein | NIH | |||||||
| Photocurable Medical Device |
SNP-001 | Bone Grafting Material |
[4] | Licensed Out | G Company | |||||
| SNP-002 | Dura Sealant | [4] | In-House | |||||||
| SNP-003 | Wound Dressing | [3] | In-House | |||||||
| SNP-004 | Veterinary Ocular Sealant |
[3] | In-House | |||||||
| SNP-005 | HA Filler | [4] | Licensed Out | J Company | ||||||
| SRP-001 | TARE | [3] | DIRAMS | |||||||